Sarah Hendry/LinkedIn, Samuel Young/LinkedIn
Jun 13, 2026, 16:45
Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
Sarah Hendry, Franchise Head, Hematology/Oncology at Spherix Global Insights, shared a post on LinkedIn:
”Pumped to be starting a packed day 2 at EHA 2026 with Samuel Young and Spherix Global Insights!
We have a poster presentation looking at gene therapy uptake dynamics in hemophilia and hemoglobinopathies tonight in poster hall A – hope to see you there!”
Stay updated with Hemostasis Today.
-
Jun 13, 2026, 16:43Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026
-
Jun 13, 2026, 16:21Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026
-
Jun 13, 2026, 16:07Isabelle Mahé: Connecting Expertise in Antithrombotic Care at ISTH 2026
-
Jun 13, 2026, 16:02Tarun Aurora։ Towards Better Risk Stratification in Sickle Cell Disease
-
Jun 13, 2026, 15:59Irene Cuppari: Whole Blood and Component Therapy in Traumatic Hemorrhage
-
Jun 13, 2026, 15:39Ritu Verma: Recognizing Deep Vein Thrombosis Before Complications Arise
-
Jun 13, 2026, 15:09Akshat Jain: Does Mitapivat Translate to Clinical Benefit in SCD?
-
Jun 13, 2026, 14:58Olga Benítez Hidalgo: New Evidence on Marstacimab in Hemophilia Care
-
Jun 13, 2026, 14:52Sophie Georgin-Lavialle: First ERN-RITA Recommendations on USAID